On this page
Familial atrial fibrillation
This inherited condition causes episodes of atrial fibrillation, which can lead to symptoms like palpitations and shortness of breath. It affects individuals with specific genetic changes that influence heart rhythm, often running in families.
Overview
Familial atrial fibrillation (AF) is a type of atrial fibrillation that clusters in families, suggesting a genetic basis [PMID:32525330]. Atrial fibrillation is a common heart rhythm disorder where the heart's upper chambers (atria) beat chaotically and often rapidly. This irregular electrical activity can lead to inefficient blood pumping, causing a range of symptoms and potential complications. When AF is familial, it means that genetic factors are thought to play a significant role in its development, often with an earlier age of onset compared to non-familial forms. Understanding the genetic component helps in identifying at-risk family members and guiding personalised management approaches.
While sporadic AF is often linked to factors like high blood pressure, obesity, or other heart conditions, familial AF occurs due to inherited genetic changes that directly impact the heart's electrical system [PMID:25316131]. This distinction is crucial for diagnosis and for understanding the risk within a family. Individuals with familial AF may experience symptoms such as palpitations, dizziness, fatigue, and shortness of breath.
Symptoms & clinical features
The symptoms of familial atrial fibrillation are similar to those of other forms of AF, but they may appear at a younger age. Common symptoms include a sensation of a racing, fluttering, or pounding heart (palpitations). This can be accompanied by feelings of light-headedness or dizziness, especially during episodes of rapid heart rate. Some individuals may experience shortness of breath, particularly during physical activity, or general fatigue, as the heart's efficiency is reduced.
Less commonly, symptoms might include chest pain or discomfort. In some cases, individuals may not experience any noticeable symptoms, and the condition is only discovered during a routine medical examination or investigation for an unrelated issue. The severity and frequency of symptoms can vary widely among affected individuals, even within the same family.
Video: Genetics 101
Affected organs
Familial atrial fibrillation primarily affects the heart, specifically the atria - the two upper chambers. These chambers are responsible for collecting blood and pumping it into the lower chambers (ventricles). In AF, the electrical signals that coordinate the atrial contractions become disorganised, leading to a rapid and irregular twitching rather than a coordinated beat. This electrical dysfunction compromises the heart's ability to effectively pump blood throughout the body.
Over time, persistent atrial fibrillation can lead to changes in the heart's structure and function, potentially affecting the ventricles as well. The disorganised electrical activity and inefficient blood flow are the main issues, but the direct impact is largely confined to the cardiac muscle and its electrical conduction system.
Risks & severity
The severity of familial atrial fibrillation can vary significantly. Some individuals may experience infrequent, short episodes with mild symptoms, while others might have persistent AF with more severe and debilitating symptoms. A key risk associated with AF, regardless of its cause, is an increased likelihood of stroke [PMID:25316131]. This occurs because the irregular heart rhythm can lead to blood pooling and forming clots in the atria, which can then travel to the brain.
Familial AF can also increase the risk of heart failure over time, as the heart works less efficiently. The age of onset can vary, but individuals with familial forms often develop the condition at a younger age than those with non-familial AF. There is a variable lifetime risk; if a causative genetic change is identified, the risk for carriers is significantly higher than the general population. Close medical monitoring is often recommended to manage symptoms and reduce potential complications.
Genetic causes
Familial atrial fibrillation is linked to changes in several genes that play crucial roles in the heart's electrical activity. Key genes implicated include GJA5, KCNQ1, and NPPA. These genes provide instructions for making proteins that are essential for the normal functioning of heart cells, particularly in regulating electrical impulses and communication between cells.
The GJA5 gene encodes a protein called connexin 40, which forms gap junctions - channels that allow electrical signals to pass directly between heart muscle cells. Pathogenic variants in GJA5 can disrupt this crucial cell-to-cell communication, leading to irregular electrical patterns in the atria [PMID:32525330]. KCNQ1 produces a protein that forms part of a potassium channel. These channels are vital for the normal repolarisation (recharging) of heart cells after an electrical impulse. Changes in KCNQ1 can alter this process, making the heart more prone to abnormal rhythms. The NPPA gene codes for natriuretic peptide A, a hormone involved in regulating blood pressure and fluid balance, and also plays a role in cardiac function. Pathogenic variants in these genes can lead to altered ion channel function, disrupted electrical signalling, or structural changes within the heart, all of which contribute to the development of atrial fibrillation.
- GJA5 gap junction protein alpha 5
- KCNQ1 potassium voltage-gated channel subfamily Q member 1The KCNQ1 gene provides instructions for making a protein that forms a critical part of voltage-gated potassium channels, which are essential for regulating electrical signals in the heart and inner ear.
- NPPA natriuretic peptide A
Inheritance pattern
Familial atrial fibrillation typically follows an autosomal dominant inheritance pattern. This means that a person only needs to inherit one copy of an altered gene from one parent to develop the condition. If a parent has a genetic change associated with familial AF, there is a 50% chance with each pregnancy that their child will inherit the same genetic change.
Individuals who inherit the genetic change may or may not develop symptoms of atrial fibrillation, or they may develop them at different ages and with varying severity. This is known as reduced penetrance and variable expressivity. The condition affects males and females equally. Family members of someone diagnosed with familial AF may be offered genetic counselling to discuss their own risks and testing options.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
Diagnosing familial atrial fibrillation often begins with a clinical suspicion based on symptoms and a family history of AF. Initial investigations typically include an electrocardiogram (ECG) to capture the heart's electrical activity, and potentially a Holter monitor or other wearable devices for continuous rhythm monitoring over an extended period. Echocardiography might also be used to assess the heart's structure and function.
Once a clinical diagnosis of AF is made and a family history suggests a genetic component, genetic testing may be offered. This usually involves a blood sample to look for pathogenic variants in genes known to be associated with familial AF, such as GJA5, KCNQ1, and NPPA. In the UK, genetic testing for suspected inherited cardiac conditions, including familial AF, is generally accessed via a referral to an NHS Clinical Genetics service, often under specific NHS Genomic Medicine Service (GMS) pathways. Relevant R-codes may include R136 (inherited cardiac conditions) or R137 (complex arrhythmias), depending on the specific clinical scenario. A definitive genetic diagnosis can help confirm the familial nature of the condition and guide cascade testing for at-risk relatives.
Management & lifestyle
Management for familial atrial fibrillation focuses on controlling the heart rhythm, managing symptoms, and reducing the risk of complications like stroke. This typically involves a multidisciplinary approach, often coordinated by a cardiologist specialising in electrophysiology. Medications such as beta-blockers, calcium channel blockers, or antiarrhythmic drugs may be prescribed to control heart rate or rhythm. For stroke prevention, anticoagulant medications are commonly used, especially in individuals with additional risk factors.
Non-pharmacological interventions can include catheter ablation, a procedure to isolate or destroy the heart tissue causing the irregular electrical signals. Lifestyle modifications, such as managing blood pressure, maintaining a healthy weight, limiting alcohol and caffeine intake, and regular physical activity, can also be beneficial. Individuals with familial AF should have regular follow-up appointments to monitor their condition. Genetic counsellors can provide support and information regarding the genetic aspects, inheritance patterns, and implications for family members, helping them navigate screening and testing options within the NHS framework.
UK care pathway
In the UK, individuals suspected of having familial atrial fibrillation would typically be referred by their GP or a general cardiologist to an NHS Clinical Genetics service. This referral would often be made following an initial diagnosis of atrial fibrillation and the identification of a significant family history. The Clinical Genetics team would then assess the need for genetic testing, usually under the NHS Genomic Medicine Service (GMS) pathways. Relevant testing is often covered by GMS R-codes, such as R136 for inherited cardiac conditions or R137 for complex arrhythmias.
Genetic counsellors, who are part of the Clinical Genetics team, play a vital role. They provide information about the condition, discuss inheritance patterns, explain the implications of genetic testing for the individual and their family, and offer support through the diagnostic process. If a causative genetic variant is identified, they can facilitate cascade screening for at-risk relatives.
Frequently asked questions
What is the difference between familial and non-familial atrial fibrillation?
Familial atrial fibrillation is caused by inherited genetic changes that directly affect the heart's electrical system, often leading to earlier onset. Non-familial (or sporadic) AF is more commonly linked to other factors like ageing, high blood pressure, or obesity, without a clear genetic cause running in the family.
If I have familial atrial fibrillation, what does this mean for my children?
Familial atrial fibrillation typically follows an autosomal dominant inheritance pattern. This means there is a 50% chance with each child that they will inherit the genetic change associated with the condition. They may or may not develop symptoms.
Can lifestyle changes help manage familial atrial fibrillation?
Yes, alongside medical treatments, lifestyle changes can be beneficial. These include maintaining a healthy weight, managing blood pressure, regular physical activity, and limiting alcohol and caffeine intake. These actions can help reduce the frequency and severity of AF episodes.
What kind of specialist will manage my familial atrial fibrillation?
Your care will typically be managed by a cardiologist, often one with a specialism in electrophysiology (heart rhythm disorders). You may also be referred to a Clinical Genetics service for genetic testing and counselling for yourself and your family.
Is familial atrial fibrillation always severe?
The severity can vary greatly. Some individuals experience mild, infrequent episodes, while others may have more frequent or persistent AF with more noticeable symptoms and a higher risk of complications. Regular monitoring and appropriate management are important for everyone with the condition.
References
- PHAIR WB. FAMILIAL ATRIAL FIBRILLATION. Canadian Medical Association journal. 1963. PMID: 14098892
- Fauchier L, Bisson A, Clementy N. Prognosis in Familial Atrial Fibrillation. Journal of the American Heart Association. 2016. PMID: 27866163
- Ragab AAY, Sitorus GDS, Brundel BBJJM. The Genetic Puzzle of Familial Atrial Fibrillation. Frontiers in cardiovascular medicine. 2020. PMID: 32118049
- Vad OB, Olesen MS. Unlocking the Genetic Code: Novel Insights Into Familial Atrial Fibrillation and Gene-Variant Interactions. The Canadian journal of cardiology. 2024. PMID: 38042338
- Roberts R, Brugada R. Genetics and arrhythmias. Annual review of medicine. 2003. PMID: 12525675
- Turkieltaub Paredes MR, Hulsurkar M, Wehrens XHT. Gene Therapy for Inherited Cardiac Arrhythmias. Journal of cardiovascular translational research. 2025. PMID: 41166050
- O'Reilly M, Sommerfeld LC, O'Shea C. Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the effect of flecainide. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2023. PMID: 36504385
- Sabeh MK, MacRae CA. The genetics of atrial fibrillation. Current opinion in cardiology. 2010. PMID: 20224389